Condition: Sexually Transmitted Infections (STI) · Sponsor: Emory University
This study is being done to test the effects of doxycycline on inflammation and the bacteria in the body in people with HIV and in people on HIV pre-exposure prophylaxis. This drug is approved by the Food and Drug Administration (FDA) for the treatment of bacterial infections. The study team will investigate whether the drug has additional effects on inflammation or on the bacteria that live in the body.
This description comes directly from the study's public registry record.
Colleen Kelley, MD, MPH · 404-712-1823 · kelley@emory.edu
Always discuss trial participation with your own doctor first.
| Grady Health System (non-CRN) | Atlanta, Georgia, United States | Recruiting |
| Hope Clinic | Atlanta, Georgia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07215325